Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $53.57M.
ENTERPRISE VALUE (EV)
$53.57M
Gain Therapeutics, Inc.
Market Cap
$74.00M
Enterprise Value (EV)
$53.57M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Gain Therapeutics, Inc. (GANX) | $74.00M | $53.57M |
| Outset Medical, Inc. (OM)vs › | $76.47M | $145.91M |
| Hyperfine, Inc. (HYPR)vs › | $76.59M | $46.54M |
| Neonc Technologies Holdings, Inc. (NTHI)vs › | $77.80M | $76.15M |
| MindWalk Holdings Corp. (HYFT)vs › | $70.25M | $67.29M |
| Fortress Biotech, Inc. (FBIO)vs › | $69.26M | N/A |
| Inovio Pharmaceuticals, Inc. (INO)vs › | $79.46M | $55.93M |
| Champions Oncology, Inc. (CSBR)vs › | $68.84M | $75.45M |
| Pulmonx Corporation (LUNG)vs › | $80.04M | $80.41M |
| Citius Oncology, Inc. (CTOR)vs › | $80.37M | $74.02M |
Market Cap
$74.00M
Total Debt
$400953.00
Cash
$20.84M
Enterprise Value
$53.57M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
